Ubs Asset Management Americas Inc Vera Therapeutics, Inc. Transaction History
Ubs Asset Management Americas Inc
- $379 Billion
- Q1 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 98,013 shares of VERA stock, worth $2.05 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
98,013
Previous 80,106
22.35%
Holding current value
$2.05 Million
Previous $3.39 Million
30.5%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding VERA
# of Institutions
196Shares Held
63.9MCall Options Held
723KPut Options Held
186K-
Avoro Capital Advisors LLC New York, NY5.7MShares$119 Million2.22% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.75MShares$99.4 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$69.8 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$61.9 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.92MShares$61 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $565M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...